TRK-380
TRK-380 (TAC-301) is a potent and selective β3-adrenergic receptor agonist. It has demonstrated efficacy in preclinical models, reducing formalin-induced frequent urination in rats and inhibiting carbachol-induced bladder contraction in dogs by 37.6%, supporting its research use in urology and overactive bladder studies.
Product Specifications
Smiles
Unknown
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
035988-ML650 100 µL
GDI2, ID (GDI2, RABGDIB, Rab GDP dissociation inhibitor beta, Guanosine diphosphate dissociation inhibitor 2) (MaxLight 650) discontinued
Sign In for Pricing
View Details